
Evaluating Biomarkers in Irinotecan Colorectal Therapy
In the relentless pursuit of personalized cancer therapy, a groundbreaking study known as the OPTIMA trial is poised to redefine the treatment landscape for advanced colorectal cancer (CRC) patients undergoing irinotecan-based systemic therapy. Colorectal …